Journal of Applied Physiology AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 103: 735-736, 2007. First published July 19, 2007; doi:10.1152/japplphysiol.00751.2007
8750-7587/07 $8.00
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/3/735    most recent
00751.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ludwig, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ludwig, M. S.

INVITED EDITORIAL

Proteoglycans and pathophysiology

Mara S. Ludwig

Meakins Christie Laboratories, McGill University, Montreal, Quebec, Canada

VENTILATION-INDUCED LUNG INJURY (VILI) is an important clinical entity whose pathophysiology is incompletely understood. The article by Moriondo and coworkers (14) in the Journal of Applied Physiology offers new insights into potential mechanistic pathways. These authors report that one of the earliest responses to mechanical ventilation in healthy rats is evidence of proteoglycan (PG) fragmentation. Changes in glycosaminoglycan (GAG) sidechain binding to core protein, as demonstrated by enhanced washout of GAG fragments, preceded changes in lung mechanical behavior. With larger tidal volumes, the effect of ventilation on pulmonary GAGs progressively increased. In contrast, only at the highest level of tidal volume ventilation was a consistent change in lung compliance observed. One may conclude that monitoring changes in extracellular matrix PG may be a more reliable indicator of ventilation-induced lung injury than pulmonary mechanics.

Proteoglycans, a key component of extracellular matrices, are macromolecules consisting of a protein core and GAG sidechains (8). The GAG sidechains include chondroitin sulfate (CS), keratin sulfate (KS), heparan sulfate (HS), dermatin sulfate (DS), and hyaluronic acid (HA), a GAG that is not bound to a protein core. Different subclasses of proteoglycans have been described and include large, aggregating proteoglycans, such as versican and aggrecan; basement membrane proteoglycans, such as perlecan; small leucine-rich repeat proteoglycans (SLRP), such as decorin, biglycan, lumican, and fibromodulin; and cell surface proteoglycans, such as syndecan (8). Members of all these PG families have been identified in the lung.

Proteoglycans subserve a number of different biologic functions. Versican, because of the high ionic charge of its multiple GAG sidechains, plays a critical role in determining the water content or turgor of extracellular matrices. Via this mechanism, versican influences tissue viscoelastic behavior, as well as cell migration and proliferation. Basement membrane proteoglycans are important components of alveolar and pulmonary capillary basal laminae; perlecan is likely the predominant molecule in the lung (15). These molecules help define functional compartments and act as filtration barriers. Cell surface PGs, such as syndecan, have been described in lung epithelial cells and function primarily as cell surface receptors for matrix ligands (12). The SLRPs, decorin and biglycan, bind to collagen and affect collagen fibrillogenesis and matrix assembly. Through their coating of collagen fibrils, they can also act to protect the fibrils from cleavage by collagenases (7). These molecules also bind different growth factors, such as transforming growth factor (TGF)-beta and fibroblast growth factor (FGF), and by influencing their bioavailability, modulate their ability to influence cell proliferation and matrix deposition (19).

There is some information reported in the literature documenting alterations in extracellular matrix (ECM) molecules in response to abnormal ventilatory regimens. Berg and colleagues (3) reported that high lung inflation resulted in increased mRNA for various ECM components. In an in vitro system, Breen (4) showed that collagen mRNA was upregulated in response to excessive mechanical strain. Increased message for ECM molecules could represent an autoregulatory response to strain-induced increases in ECM breakdown. Little information is available, however, concerning the effects of mechanical strain on the PG components of the ECM. We showed in a model of large tidal volume ventilation in healthy rats (2) that, at the largest tidal volume, expression of versican, HSPG, and biglycan protein core in extracts of lung tissue was increased. We did not, however, examine changes in GAG per se or level of GAG fragmentation. Alveolar overdistension leads to plasma membrane stress failure (23). Syndecan, the most common cell surface PG, has primarily HS sidechains. Increased HS fragmentation, such as was seen in the experiment of Moriondo et al. (14), may be a consequence of ventilation-induced plasma membrane disruption.

Changes in PG in response to mechanical perturbations would be expected to lead to alterations in the mechanical properties of the lung. Proteoglycans contribute to the viscous properties of the lung parenchyma. The hydrophilic GAG sidechains attract ions and fluid into the matrix, thereby affecting tissue turgor and viscoelasticity (5, 8). Versican is a large, hydrodynamic molecule with numerous CS sidechains (8). As versican is the predominant PG present in the ECM of the lung parenchyma, it seems likely this PG plays a key role in determining the turgor of the parenchymal tissues. Cavalcante et al. (5) postulated that PG act to stabilize the collagen-elastin network of connective tissues via their effects on tissue osmolarity. Negrini and colleagues (13, 16) published a series of papers showing that proteoglycans critically influence the development of edema via their effects on interstitial tissue compliance. We published experimental data that directly implicate proteoglycans as determinants of the viscoelastic behavior of the lung tissues (1). Parenchymal strips were excised from rat lungs, and tissue viscoelastic properties were measured in the organ bath. Exposure of the tissues to the specific degradative enzymes, chondroitinase and heparitinase, which digest GAG sidechains, resulted in alterations in tissue viscoelastic behavior, including increased tissue elastance (1). We also obtained data in decorin-deficient mice, characterizing the viscoelastic behavior of the lung, both in intact animals, and again, in isolated lung parenchymal strips (6). The in vivo and in vitro lung elastic properties of decorin-deficient mice were different from those of wild-type, decorin-replete mice. Hence, alterations in GAGs in response to mechanical ventilation, such as was documented by Moriondo et al. (14), may represent a primary event that ultimately leads to the altered physiology characteristic of VILI.

A further mechanism by which altered PG may contribute to the pathology seen in response to excessive ventilation is through their putative proinflammatory effects. GAGs have been shown to demonstrate highly specific interactions with various chemokines, such as CCL5/RANTES, CCL2, MCP-1, and CXCL8/IL-8 (11). Furthermore, PGs may act as ligands for proinflammatory Toll-like receptors (20). Hence, fragmentation of GAGs and breakdown of PG may have an impact on the development of the inflammatory response seen in VILI.

Finally, the concept of "matrikines" is worth considering. Matrikines are a new class of ligands that exist as a domain within an ECM protein. Natural matrikines are those that signal directly from the ECM, and cryptic matrikines are those that require proteolytic breakdown for the ligand to be revealed (21). Decorin is an example of a proteoglycan matrikine; it functions through the EGF receptor and activates downstream signaling pathways, such as ERK1/ERK2 (17). It is plausible that the breakdown of ECM proteins observed in the rat ventilation model leads to exposure of matrikines, which can then act as ligands to induce subsequent biologic effects.

The observation that mechanical ventilation results in PG breakdown and GAG fragmentation is an important one, and highlights the potential role that these molecules may play in the subsequent pathophysiological process. They may be important in influencing the altered mechanical behavior of the lung and in contributing to subsequent inflammatory events and the altered biology characteristic of ventilation-induced lung injury. The observation of early GAG fragmentation may also have pertinence to other disease processes characterized by abnormal mechanical strain or stress. Suki and colleagues (9, 10) recently highlighted the potential importance of altered mechanical stress in the development of emphysema. It is possible that a part of the process relates to the excessive breakdown of matrix components and the subsequent effects on lung biology. Excessive mechanical strain may also play a role in the airway wall remodeling typical of asthma; proteoglycan deposition is altered in the asthmatic airway (18, 22). Hence changes in proteoglycans in response to mechanical stimuli may potentially contribute to the pathophysiology of a number of clinically important lung diseases.

FOOTNOTES


Address for reprint requests and other correspondence: M. S. Ludwig, Meakins-Christie Laboratories, McGill Univ., 3626 St. Urbain St., Montreal, QC, Canada H2X 2P2 (e-mail: mara.ludwig{at}mcgill.ca)

REFERENCES

  1. Al Jamal R, Roughley PJ, Ludwig MS. Effect of glycosaminoglycan degradation on lung tissue viscoelasticity. Am J Physiol Lung Cell Mol Physiol 280: L306–L315, 2001.[Abstract/Free Full Text]
  2. Al Jamal R, Ludwig MS. Changes in proteoglycans and lung tissue mechanics during excessive mechanical ventilation in rats. Am J Physiol Lung Cell Mol Physiol 281: L1078–L1087, 2001.[Abstract/Free Full Text]
  3. Berg JT, Fu Z, Breen EC, Tran HC, Mathieu-Costello O, West JB. High lung inflation increases mRNA levels of ECM components and growth factors in lung parenchyma. J Appl Physiol 83: 120–128, 1997.[Abstract/Free Full Text]
  4. Breen EC. Mechanical strain increases type I collagen expression in pulmonary fibroblasts in vitro. J Appl Physiol 88: 203–209, 2000.[Abstract/Free Full Text]
  5. Cavalcante FS, Ito S, Brewer K, Sakai H, Alencar AM, Almeida MP, Andrade JS Jr, Majumdar A, Ingenito EP, Suki B. Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue. J Appl Physiol 98: 672–679, 2005.[Abstract/Free Full Text]
  6. Fust A, LeBellego F, Iozzo RV, Roughley PJ, Ludwig MS. Alterations in lung mechanics in decorin-deficient mice. Am J Physiol Lung Cell Mol Physiol 288: L159–L166, 2005.[Abstract/Free Full Text]
  7. Geng Y, McQuillan D, Roughley PJ. SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol 25: 484–491, 2006.[CrossRef][ISI][Medline]
  8. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67: 609–652, 1998.[CrossRef][ISI][Medline]
  9. Ito S, Bartolak-Suki E, Shipley JM, Parameswaran H, Majumdar A, Suki B. Early emphysema in the tight skin and pallid mice: roles of microfibril-associated glycoproteins, collagen, and mechanical forces. Am J Respir Cell Mol Biol 34: 688–694, 2006.[Abstract/Free Full Text]
  10. Ito S, Ingenito EP, Brewer KK, Black LD, Parameswaran H, Lutchen KR, Suki B. Mechanics, nonlinearity, and failure strength of lung tissue in a mouse model of emphysema: possible role of collagen remodeling. J Appl Physiol 98: 503–511, 2005.[Abstract/Free Full Text]
  11. Johnson Z, Proudfoot AE, Handel TM. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 16: 625–636, 2005.[CrossRef][ISI][Medline]
  12. Maniscalco WM, Campbell MH. Alveolar type II cells synthesize hydrophobic cell-associated proteoglycans with multiple core proteins. Am J Physiol Lung Cell Mol Physiol 263: L348–L356, 1992.[Abstract/Free Full Text]
  13. Miserocchi G, Negrini D, Passi A, De LG. Development of lung edema: interstitial fluid dynamics and molecular structure. News Physiol Sci 16: 66–71, 2001.[Abstract/Free Full Text]
  14. Moriondo A, Pelosi P, Passi A, Viola M, Marcozzi C, Severgnini P, Ottani V, Quaranta M, Negrini D. Proteoglycans fragmentation and respiratory mechanics in mechanically ventilated healthy rats. J Appl Physiol; doi:10.1152/japplphysiol.00056.2007.
  15. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem 267: 8544–8557, 1992.[Abstract/Free Full Text]
  16. Negrini D, Passi A, De LG, Miserochi G. Proteoglycan involvement during development of lesional pulmonary edema. Am J Physiol Lung Cell Mol Physiol 274: L203–L211, 1998.[Abstract/Free Full Text]
  17. Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 273: 3121–3124, 1998.[Abstract/Free Full Text]
  18. Pini L, Hamid Q, Shannon J, Lemelin L, Olivenstein R, Ernst P, Lemiere C, Martin JG, Ludwig MS. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J 29: 71–77, 2007.[Abstract/Free Full Text]
  19. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 64: 867–869, 1991.[CrossRef][ISI][Medline]
  20. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, Malle E, Schaefer RM, Grone HJ. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115: 2223–2233, 2005.[CrossRef][ISI][Medline]
  21. Tran KT, Griffith L, Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 12: 262–268, 2004.[CrossRef][ISI][Medline]
  22. Tschumperlin DJ, Drazen JM. Mechanical stimuli to airway remodeling. Am J Respir Crit Care Med 164: S90–S94, 2001.[Abstract/Free Full Text]
  23. Vlahakis NE, Hubmayr RD. Plasma membrane stress failure in alveolar epithelial cells. J Appl Physiol 89: 2490–2496, 2000.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/3/735    most recent
00751.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ludwig, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ludwig, M. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.